Vitamin C reversed migratory dysfunction of mononuclear cells in smokers

Vitamin C reversed migratory dysfunction of mononuclear cells in smokers - VICM

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000430

Enrollment

Registered

2006-08-01

Start date

2005-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy young male smokers who does not have coronary risk factors without smoking

Interventions

2 weeks administration of Vitamin C(3.0g/day, smokers) Non-smokers does not take Vitamin C.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy young smokers without coronary risk factor.

Exclusion criteria

Exclusion criteria: Patient with coronary risk factors.

Design outcomes

Primary

Measure	Time frame
Migratory function of mononuclear cells	—

Countries

Japan

Contacts

Public ContactYoshio Katsuki

Kurume University Department of intarnal medicine division of cardio-vascular medicine

katsuki_yoshio@kurume-u.ac.jp0942-35-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026